Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026
Same author

The construct validity of real-world digital mobility outcomes in people with COPD.

ERJ open research·2026
Same author

Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.

Journal of the neurological sciences·2026
Same author

RETINAL DETACHMENT AFTER ENDOGENOUS ENDOPHTHALMITIS: A Multicenter Study.

Retina (Philadelphia, Pa.)·2026
Same author

Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics.

Trials·2026
Same author

MR-guided reconstruction of PET data in spinal cord PET/MRI.

Frontiers in nuclear medicine·2025
Same journal

Vasa Vasorum-A Silent Enemy After EVAR: A Case Report and Review of the Literature.

Clinics and practice·2026
Same journal

Post-Levothyroxine Thyroid Dysfunction in Saudi Arabian Patients with Hypothyroidism: A Cross-Sectional Study.

Clinics and practice·2026
Same journal

Pycnodysostosis: Report of Two Novel CTSK Variants in a Child.

Clinics and practice·2026
Same journal

Prevalence of and Factors Associated with Overactive Bladder, Anxiety, and Depression Among Patients with Multiple Sclerosis: A Cross-Sectional Study in Saudi Arabia.

Clinics and practice·2026
Same journal

Trends in Comorbidity for Patients with Venous Thromboembolism in a General Hospital: 2018 to 2022.

Clinics and practice·2026
Same journal

Beyond Coiling: A Comparative Analysis of Survey-Reported Preferences for Endovascular Cerebral Aneurysm Occlusion.

Clinics and practice·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K

Multiple sclerosis in an adrenoleukodystrophy carrier.

Thomas Jenkins1, Priya Sarasamma2, Godfrey Gillett3

  • 1Department of Neurology; ; Sheffield Institute for Translational Neuroscience;

Clinics and Practice
|April 26, 2014
PubMed
Summary
This summary is machine-generated.

This case study highlights a female X-linked adrenoleukodystrophy (X-ALD) carrier initially presenting with symptoms suggestive of multiple sclerosis (MS). It emphasizes considering common diagnoses alongside rare genetic conditions.

Keywords:
adrenoleukodystrophy.multiple sclerosis

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

29.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

4.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

29.7K

Area of Science:

  • Neurology
  • Genetics
  • Metabolic Disorders

Background:

  • X-linked adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder characterized by very long chain fatty acid (VLCFA) accumulation, primarily affecting males but potentially causing symptoms in female carriers.
  • Neurological complications in female X-ALD carriers can manifest, though often less severe than in affected males.

Observation:

  • A young adult female, identified as a heterozygous carrier for X-ALD, presented with episodic sensorimotor symptoms.
  • Clinical presentation and diagnostic investigations were more indicative of multiple sclerosis (MS) than X-ALD pathology.

Findings:

  • This is the first reported case of a female X-ALD carrier whose symptoms were primarily consistent with co-existing multiple sclerosis.
  • The patient's presentation underscores the diagnostic challenge in differentiating X-ALD-related symptoms from other neurological conditions in female carriers.

Implications:

  • Highlights the importance of considering common neurological diagnoses, such as MS, even in patients with rare genetic predispositions like X-ALD.
  • Suggests a need for comprehensive diagnostic approaches in female carriers of X-ALD presenting with neurological symptoms.
  • Emphasizes that carrier status for rare diseases does not exclude the possibility of concurrent, more prevalent conditions.